# Resmed Reports Higher Profit but Lower Operating Margin and Cash Flow

Quarterly revenue rose 6% to $1.415 billion, while the company maintained its fiscal 2027 guidance.

By Will Langan | 24X7 News
Published: 2026-10-29T22:00:20.754Z
Updated: 2026-10-29T22:00:20.754Z
Section: Health
Format: News
Canonical: https://24x7news.us/articles/resmed-first-quarter-results-october-29-2026

Resmed reported October 29 that revenue rose 6% from a year earlier to $1.415 billion in its fiscal first quarter, while net income increased 20% to $418 million.

GAAP diluted earnings per share rose to $2.92 from $2.37. Adjusted diluted earnings, which exclude specified items, increased to $2.91 from $2.55.

The sleep and breathing technology company reported a GAAP operating margin of 32%, down from 33.4% a year earlier. Operating income increased 1% to $453 million.

Operating cash flow declined 8% to $422 million. Free cash flow, which deducts capital expenditures, fell 10% to $374 million.

Resmed said proceeds from its completed MatrixCare divestiture and cash generation supported more than $1 billion in dividends and share repurchases during the quarter ended September 30.

The company maintained fiscal 2027 revenue guidance of $5.75 billion to $5.85 billion and adjusted diluted earnings guidance of $12–$12.25 per share.

Those figures are forecasts. The reported growth does not establish treatment outcomes for individual patients or predict future performance.

Sources:
Resmed — October 29 Financial Results: https://investor.resmed.com/news-events/press-releases/detail/433/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2027

## Sources
- Resmed — October 29 Financial Results: https://investor.resmed.com/news-events/press-releases/detail/433/resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2027